Kathiravan M - Search Results

Year	Number of Results
2007	2
2008	1
2009	2
2010	4
2011	5
2012	4
2013	5
2014	6
2015	3
2016	3
2017	1
2018	3
2019	3
2020	2
2021	3
2022	2
2023	6
2024	7

1

The biology and chemistry of hyperlipidemia.

Jain KS, Kathiravan MK, Somani RS, Shishoo CJ. Jain KS, et al. Among authors: kathiravan mk. Bioorg Med Chem. 2007 Jul 15;15(14):4674-99. doi: 10.1016/j.bmc.2007.04.031. Epub 2007 Apr 25. Bioorg Med Chem. 2007. PMID: 17521912 Review.

2

Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).

Vanangamudi M, Palaniappan S, Kathiravan MK, Namasivayam V. Vanangamudi M, et al. Among authors: kathiravan mk. Viruses. 2023 Sep 25;15(10):1992. doi: 10.3390/v15101992. Viruses. 2023. PMID: 37896769 Free PMC article. Review.

3

An overview of mechanism and chemical inhibitors of shikimate kinase.

Chagaleti BK, Reddy MBR, Saravanan V, B S, D P, Senthil Kumar P, Kathiravan MK. Chagaleti BK, et al. Among authors: kathiravan mk. J Biomol Struct Dyn. 2023;41(23):14582-14598. doi: 10.1080/07391102.2023.2193985. Epub 2023 Mar 28. J Biomol Struct Dyn. 2023. PMID: 36974959 Review.

4

Mycothiol: a promising antitubercular target.

Nilewar SS, Kathiravan MK. Nilewar SS, et al. Among authors: kathiravan mk. Bioorg Chem. 2014 Feb;52:62-8. doi: 10.1016/j.bioorg.2013.11.004. Epub 2013 Nov 21. Bioorg Chem. 2014. PMID: 24368170 Review.

5

The biology and chemistry of antifungal agents: a review.

Kathiravan MK, Salake AB, Chothe AS, Dudhe PB, Watode RP, Mukta MS, Gadhwe S. Kathiravan MK, et al. Bioorg Med Chem. 2012 Oct 1;20(19):5678-98. doi: 10.1016/j.bmc.2012.04.045. Epub 2012 May 9. Bioorg Med Chem. 2012. PMID: 22902032 Review.

6

Topoisomerase as target for antibacterial and anticancer drug discovery.

Kathiravan MK, Khilare MM, Nikoomanesh K, Chothe AS, Jain KS. Kathiravan MK, et al. J Enzyme Inhib Med Chem. 2013 Jun;28(3):419-35. doi: 10.3109/14756366.2012.658785. Epub 2012 Mar 1. J Enzyme Inhib Med Chem. 2013. PMID: 22380774 Review.

7

Deuterated driven new chemical entities: An optimistic way to improve therapeutic efficacy.

Chandra Mouli HM, Vinod A, Kumari S, Tiwari AK, Kathiravan MK, Ravichandiran V, Peraman R. Chandra Mouli HM, et al. Among authors: kathiravan mk. Bioorg Chem. 2023 Jun;135:106490. doi: 10.1016/j.bioorg.2023.106490. Epub 2023 Mar 22. Bioorg Chem. 2023. PMID: 37001472 Review.

8

Inhibition of glutamine synthetase: a potential drug target in Mycobacterium tuberculosis.

Mowbray SL, Kathiravan MK, Pandey AA, Odell LR. Mowbray SL, et al. Among authors: kathiravan mk. Molecules. 2014 Aug 26;19(9):13161-76. doi: 10.3390/molecules190913161. Molecules. 2014. PMID: 25162957 Free PMC article. Review.

9

An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus.

Kathiravan MK, Radhakrishnan S, Namasivayam V, Palaniappan S. Kathiravan MK, et al. Front Mol Biosci. 2021 Mar 16;8:637550. doi: 10.3389/fmolb.2021.637550. eCollection 2021. Front Mol Biosci. 2021. PMID: 33898518 Free PMC article. Review.

10

Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.

Kathiravan MK, Kale AN, Nilewar S. Kathiravan MK, et al. Mini Rev Med Chem. 2016;16(15):1219-1229. doi: 10.2174/1389557516666160822110819. Mini Rev Med Chem. 2016. PMID: 27549098 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year